Search results
Takeda’s epilepsy drug misses main goals in late-stage trials - Boston Business Journal
The Business Journals· 2 days agoTakeda Pharmaceuticals Inc. shared disappointing results from two late-stage trials for rare forms...
Regeneron CEO Leonard Schleifer sells over $25 million in company stock By Investing.com
Investing.com· 6 days agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) has reported a series of transactions by...
Diana Taurasi Is Down for One More Party
GQ· 2 days agoThis summer, she will set another record, becoming the first basketball player ever to participate in six Olympic games. Along with pharmaceutical...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks· 2 days agoFree Report) is one of the few top biotech companies that has outperformed the industry year to date. Regeneron’s efforts to diversify its portfolio have impressed its investors, even as lead ...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks via Yahoo Finance· 6 days agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop...
Preoxygenation With Noninvasive Ventilation Led to Less Hypoxemia During Intubation
MedPage Today· 7 days agoCompared with preoxygenation with an oxygen mask, preoxygenation with noninvasive ventilation led to...
Diana Taurasi says she'll 'always' wear '90s-style shorts
AZCentral | The Arizona Republic via Yahoo News· 2 days agoTreatments range from over-the-counter ointments and creams to prescription oral steroids and...
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 2 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
Diana Taurasi Is Down for One More Party
GQ via Yahoo Sports· 2 days agoThe WNBA’s all-time leading scorer on her Olympic plans in Paris, feeling like a war veteran around women’s basketball’s new generation, and her journey...
Moderna Just Gave Investors Another Reason to Buy the Stock
Motley Fool via Yahoo Finance· 3 days agoThe biotech has other key late-stage pipeline candidates. Moderna is developing a vaccine for the...